期刊文献+

高危型HPV检测联合肉眼醋酸试验在宫颈癌前病变筛查中的应用 被引量:13

The application of HPV-DNA detection combined with VIA test in screening of precancerous lesion of uterine cervix
下载PDF
导出
摘要 目的:研究在宫颈癌前病变筛查中采用高危型HPV检测联合肉眼醋酸试验的应用效果。方法:选取2007年8月~2010年2月于我院治疗的可疑宫颈癌前病变患者532例,应用5%醋酸和Lugol's液涂抹于宫颈表面,筛选出有异常着色的患者320例,再采用实时荧光定量PCR技术检测高危型HPV病毒感染情况。结果:320例肉眼醋酸试验异常着色患者进行高危型HPV病毒感染检测发现,HPV阳性感染190例,阳性率为59.38%;212例肉眼醋酸试验正常着色患者进行高危型HPV病毒感染检测发现,HPV阳性感染18例,阳性率为8.49%。结论:肉眼醋酸试验联合高危型HPV检测可及时、有效地发现宫颈癌前病变,可作为宫颈癌前病变筛查方案应用于临床。 Objective: To study the efficiency of HPV-DNA detection combined with visual inspection with acetic acid(VIA) test in screening of precancerous lesions of uterine cervix.Methods: 532 suspected precancerous lesion of uterine cervix patients in our hospital from August 2007 to February 2010 were selected.5% acetic acid and Lugol's liquid were painted on the surface of cervix of all patients,and 320 cases of patients were screened by the abnormal color.Then the real-time fluorescence quantitative polymerase chain reaction technology was used to test high risk HPV infection in all patients.Results: High risk HPV infection test of 320 patients who were showed abnormal color in VIA test was showed that 190 cases got HPV positive infection,the positive rate was 59.38%.High risk HPV infection test of 212 patients who were showed normal color in VIA test was showed that 18 cases got HPV positive infection,the positive rate was 8.49%.Conclusion: VIA test combined with HPV-DNA checking can timely and effectively discover precancerous lesion,which can be used in clinic as precancerous lesion screening plan.
作者 赵金娟
出处 《中国医药导报》 CAS 2012年第1期88-89,共2页 China Medical Herald
关键词 宫颈癌前病变 人乳头瘤病毒 肉眼醋酸试验 Precancerous lesion of uterine cervix Human papilloma virus Visual inspection with acetic acid test
  • 相关文献

参考文献17

二级参考文献40

  • 1任力群,林立鹏,罗丽娅.5615例宫颈液基细胞检测结果的分析[J].中国优生与遗传杂志,2008,16(10). 被引量:8
  • 2刘彬,陈汶,任生达,刘新伏,马俊飞,崔剑峰,王秀荣,陈凤,乔友林.液基细胞学剩余标本筛查子宫颈病变中人乳头状瘤病毒DNA的应用[J].中华检验医学杂志,2005,28(5):495-497. 被引量:18
  • 3任生达,米振国,马俊飞,张永贞,王素梅,孙立新,向喜娥,王全红,石菊芳,乔友林.适宜农村地区子宫颈癌筛查方法的研究[J].肿瘤研究与临床,2005,17(6):391-393. 被引量:21
  • 4李霓,马聪萍,孙立新,张永贞,张永贞,邢菊霞,邵淑丽,邢菊霞,鲍彦平,黄瑞德,贺立绩,乔友林.碘染色肉眼观察作为宫颈癌初筛方法的效果评价[J].中华流行病学杂志,2006,27(1):15-18. 被引量:38
  • 5屠铮,李静,赵超,宋丹,崔淑慧,章文华,乔友林,Belinson JL,魏丽惠.醋白肉眼观察试验在宫颈病变筛查中的价值[J].中国妇产科临床杂志,2007,8(2):90-92. 被引量:25
  • 6Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papiUomavirus types associated with cervical cancer[J]. N Engl J Med, 2003, 348(6): 518-527.
  • 7Sankaranarayanan R, Chatterji R, Shastri SS, et al. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India[J]. IntJ Cancer, 2004, 112(2) : 341--347.
  • 8Salmeron J, Lazcano-Ponce E, Lorincz A, et al. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico[J]. Cancer Causes Control,2003, 14(6): 505-512.
  • 9BelinsonJL, Qiao YL, Pretorius RG, et al. Shanxi Province cervical cancer screening study Ⅱ: serf--sampling for high-risk human papillomavirus compared to direct sampling for human papiUomavirus and liquid based cervical cytology[J]. Int J Gynecol Cancer, 2003, 13 (6): 819-826.
  • 10Sherman ME, Lorincz AT, Scott DR, et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis[]].J Natl Cancer Inst, 2003, 95(1): 46-52.

共引文献80

同被引文献146

  • 1刘水平,蒋海鹰,郑晖,颜亚晖,冯德云.高危型HPV在宫颈癌发生中的作用[J].实用预防医学,2005,12(5):1023-1024. 被引量:5
  • 2卫立辛,吴孟超.端粒酶:肿瘤治疗研究的新希望[J].中国肿瘤生物治疗杂志,2006,13(5):325-328. 被引量:20
  • 3Sandfi MT, Lentati P, Benini E, et al. Compari- son of the Digene HC2 As - say and the Roche AMPLICOR [ J ]. J Clin Microbiol, 2006,44 : 2141 -2146.
  • 4Guo M,Gong Y,Wang J,et al.The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraep- ithelial neoplasm in women with mildly abnormal Papanicolaou re- sults[J].Cancer Cytopathol, 2013,121 (2) : 79-85.
  • 5Cox JT,Castle PE,Behrens CM,et al.Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing,and genotyping for HPV 16/18:resuhs from the A- THENA HPV study[J]. Am J Obstet Gyneco1,2013,208 (3) : 184.
  • 6Griesser H,Sander H, Hi/filch R,et al. Correlation of im- munochemical detection of HPV L1 capsid protein in pap smears with regression of high-risk HPV positive mild/mod- erate dysplasia [J]. Anal Quant Cytol Histol,2009,26 (5) : 241-245.
  • 7Negri Q, Bellisano G, Zannoni GF,et al. p16 in k4a and HPV L Iimmunohistochemistry is helpful for estimating the behav- ior of low-grade dysplastie lesions of the cervixuteri [J]. Am J Surg pathol, 2010,32 ( 11 ) : 1715-1720.
  • 8Rauber D,Mehlhorn G,Fasching PA,et al. Prognostic sig- nificance of the detection of human papilloma virus L1 pro- tein in smears of mild to moderate cervical intraepithelial le- sions [J]. Eur J Obstet Gynecol Reprod Bioi,2008,140(2): 258-262.
  • 9Griesser H,Sander H,Hilfrich R,et al. Correlation of im- munoehemieal detection of HPV L1 eapsid protein in pap smears with regression of high risk HPV positive mild/mod- erate dysplasia [J]. Anal Quant Cytol Histol,2009,26 (9): 241-245.
  • 10Harald zur Hausen.Papillomaviruses in the causation of human cancers — a brief historical account[J]. Virology . 2008 (2)

引证文献13

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部